BMJ  2005;330:995 (30 April), doi:10.1136/bmj.38408.471991.8F (published 29 March 2005)

Paper

Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study

James A Berkley, clinical research fellow1, Kathryn Maitland, clinical research fellow1, Isaiah Mwangi, clinical researcher1, Caroline Ngetsa, laboratory technologist1, Saleem Mwarumba, laboratory technologist1, Brett S Lowe, laboratory manager1, Charles R J C Newton, senior clinical research fellow1, Kevin Marsh, professor1, J Anthony G Scott, clinical research fellow1, Mike English, clinical research fellow1

1 Centre for Geographic Medicine Research (coast), PO Box 230, Kilifi, Kenya

Correspondence to: J A Berkley jberkley{at}kilifi.mimcom.net

Abstract

Objectives To determine how well antibiotic treatment is targeted by simple clinical syndromes and to what extent drug resistance threatens affordable antibiotics.

Design Observational study involving a priori definition of a hierarchy of syndromic indications for antibiotic therapy derived from World Health Organization integrated management of childhood illness and inpatient guidelines and application of these rules to a prospectively collected dataset.

Setting Kilifi District Hospital, Kenya.

Participants 11 847 acute paediatric admissions.

Main outcome measures Presence of invasive bacterial infection (bacteraemia or meningitis) or Plasmodium falciparum parasitaemia; antimicrobial sensitivities of isolated bacteria.

Results 6254 (53%) admissions met criteria for syndromes requiring antibiotics (sick young infants; meningitis/encephalopathy; severe malnutrition; very severe, severe, or mild pneumonia; skin or soft tissue infection): 672 (11%) had an invasive bacterial infection (80% of all invasive bacterial infections identified), and 753 (12%) died (93% of all inpatient deaths). Among P falciparum infected children with a syndromic indication for parenteral antibiotics, an invasive bacterial infection was detected in 4.0-8.8%. For the syndrome of meningitis/encephalopathy, 96/123 (76%) isolates were fully sensitive in vitro to penicillin or chloramphenicol.

Conclusions Simple clinical syndromes effectively target children admitted with invasive bacterial infection and those at risk of death. Malaria parasitaemia does not justify withholding empirical parenteral antibiotics. Lumbar puncture is critical to the rational use of antibiotics.

Introduction

Invasive bacterial infections are an important cause of childhood illness and death worldwide. Advice on the management of common conditions in resource poor countries has recently been summarised by the World Health Organization.1 Diagnosis in such settings usually depends on the identification of a small number of clinical syndromes. Seriously ill children often meet criteria for several clinical syndromes, however, and different diseases may cause the same clinical syndrome.2 In malaria endemic areas the clinical manifestations of malaria overlap with those of pneumonia, bacteraemia, and meningitis.

We aimed to determine how well antibiotic treatment is targeted by simple rules based on current WHO guidelines, how application of such rules is affected by malaria parasitaemia in an endemic area, and to what extent antibiotic resistance threatens the use of cheap antibiotics.

Methods

Location and clinical methods
Kilifi District Hospital is located in a rural area on the Kenyan coast. Children receive up to 50 mosquito bites infective for Plasmodium falciparum annually, with two transmission seasons.3 Ten per cent of women attending the hospital antenatal clinic in 2000 were infected with HIV.4 Haemophilus influenzae type b conjugate vaccination had not begun at the time of the study.

We recruited all children admitted from February 1999 to December 2001, unless no diagnostic uncertainty existed. We collected clinical data, a malaria slide, full blood count, and blood culture on admission. Table 1 gives clinical definitions. Our lumbar puncture policy included any of the following at any time during admission: meningism; impaired consciousness (delayed until neurologically stable); prostration in children aged under 3 years; seizures, other than simple febrile seizures; or as a septic screen in young infants.5 Inpatient treatment followed WHO and local guidelines, including recommended protocols for severe malnutrition.1 See bmj.com for details of laboratory methods.


View this table:
[in this window]
[in a new window]
 
Table 1 Definition of clinical syndromes and currently recommended antibiotic treatment

 

Analysis
We classified children as meeting the definition of a syndrome warranting antibiotic treatment or not by using data collected on admission. We constructed an a priori hierarchy of the syndromes, reflecting prioritisation in clinical practice (figure). We assigned individual children to their highest priority syndrome. We explored the possibility that antibiotic resistance increased the risk of inpatient death by using multiple logistic regression. We labelled individuals as "resistant to treatment" if the organism isolated was resistant in vitro to the antibiotics defined by their syndrome.



View larger version (29K):
[in this window]
[in a new window]
 
Hierarchical classification of defined syndromes requiring antibiotic treatment

 

Results

Among 14 987 admissions, we analysed 11 847 admissions after exclusions (see bmj.com). We detected an invasive bacterial infection in 843 (7.1%) admissions (table 2): 633 (5.3%) positive blood culture only, 9 (< 0.1%) positive cerebrospinal fluid (CSF) culture only, 111 (0.9%) positive blood and CSF cultures, 21 (0.2%) positive blood culture with CSF evidence of meningitis, and 69 (0.6%) CSF evidence of meningitis but negative cultures. We detected P falciparum parasitaemia in 5270 (45%) admissions. A defined syndrome requiring antibiotics was present in 6254 (53%) admissions; of these, 672 (11%) had an invasive bacterial infection, representing 80% of all invasive bacterial infections, and 753 (12%) died in hospital, representing 93% of 813 inpatient deaths. See table on bmj.com for details of in vitro antimicrobial susceptibilities.


View this table:
[in this window]
[in a new window]
 
Table 2 Number of admissions with defined syndromes, prevalence of invasive bacterial infections, malaria parasitaemia, and outcome. Values are numbers (percentages) unless stated otherwise

 

Sick young infants
Of 1267 young infants, 184 (15%) had an invasive bacterial infection (table 2), principally group B streptococci, Escherichia coli, Acinetobacter, and Klebsiella spp. The proportion of isolates susceptible in vitro to ampicillin-gentamicin was greater than that resistant to either penicillin-gentamicin or cefotaxime (both P = 0.001).

Meningitis/encephalopathy syndrome
This clinical syndrome captured 101/160 (63%) cases of laboratory defined meningitis in children at least 60 days old; 21 (13%) other cases of meningitis outside this syndrome definition met another syndrome definition indicating parenteral antibiotics. The remaining 38 (24%) cases of meningitis would not have initially received parenteral antibiotics if syndromic treatment rules (that do not rely on lumbar puncture) had been followed absolutely. The most common isolates were Streptococcus pneumoniae and H influenzae. Four hundred and twenty two (52%) children with this syndrome had a positive malaria slide; 29 (6.9%) of these had an invasive bacterial infection compared with 117/397 (30%) children with negative slides (P < 0.001, table 2). Case fatality did not vary significantly with malaria parasitaemia. Only 76% of isolates were fully sensitive in vitro to penicillin-chloramphenicol compared with 93% for cefotaxime (P < 0.001). When we excluded H influenzae, 86% of isolates were sensitive to penicillin-chloramphenicol. Susceptibility results were similar when all meningitis cases missed by this syndrome definition were included.

Severe malnutrition syndrome
Severe malnutrition syndrome accounted for 141/659 (21%) of invasive bacterial infections and 200/533 (38%) of deaths in children aged at least 60 days (table 2). S pneumoniae, E coli, and non-typhoidal salmonellae were the most common isolates. Most (959, 81%) of these admissions did not meet criteria for another syndrome requiring antibiotics, making anthropometry or kwashiorkor the sole basis for antibiotic treatment. Of these, 88 (9.2%) had an invasive bacterial infection and 153 (16%) died, compared with 53 (24%) and 47 (21%) of the 223 who met other syndrome definitions (both P < 0.001). The prevalence of invasive bacterial infection was higher in children with negative malaria slides than in those with positive slides (P = 0.02, table 2). Case fatality was lower in admissions with negative malaria slides (166/802, 21%) than in those with positive slides (34/376, 9.0%) (P < 0.001). In vitro susceptibility to amoxicillin-gentamicin was greater than that to penicillin-gentamicin (P < 0.05).

Pneumonia syndromes
Of 2803 (24%) children admitted with a pneumonia syndrome, 1470 (52%) had severe disease and 296 (11%) had very severe disease. The prevalence of invasive bacterial infection with severe pneumonia syndrome was similar to that with mild pneumonia syndrome, but case fatality was greater (P = 0.001, table 2). S pneumoniae (38%), Enterobacteriaceae (30%), and H influenzae (15%) were the most common isolates. Three to four per cent of children with a positive malaria slide had an invasive bacterial infection compared with 6.9-16% in those with a negative slide (all P < 0.001, table 2). Case fatality did not vary significantly with malaria parasitaemia. Isolates from children with severe or very severe pneumonia were more commonly susceptible to chloramphenicol alone than to penicillin alone (P = 0.05) and to ampicillin-gentamicin than to penicillin-gentamicin (P = 0.04).

Skin or soft tissue infection syndrome
Ten (5.5%) of 182 children with skin or soft tissue infections had an invasive bacterial infection. Staphylococcus aureus accounted for four (40%) invasive infections, and all these were sensitive to cloxacillin.

No defined syndrome requiring antibiotics
Of 5593 children without a syndrome requiring antibiotics, 171 (3.1%) had an invasive bacterial infection and 60 (1.1%) died. Non-typhoidal salmonellae, S pneumoniae, and S aureus were the most common isolates. Of 2324 malaria slide negative admissions, 118 (5.1%) had an invasive bacterial infection compared with 53/3247 (1.6%) slide positive admissions (P < 0.001). Among children with an axillary temperature ≥39°C, invasive bacterial infection was present in 47/488 (9.6%) with a negative malaria slide compared with 22/1422 (1.6%) with a positive slide (P < 0.001). We found no significant association between invasive bacterial infection and prostration, seizures, diarrhoea, vomiting, jaundice, or severe anaemia. Among children with an invasive bacterial infection, 0/53 children with a positive malaria slide died compared with 11/118 (9.3%) of those with a negative slide (P = 0.02). In those without an invasive bacterial infection, 20/3194 (0.6%) children with a positive malaria slide died compared with 29/2216 (1.3%) with a negative slide (P = 0.009).

Antimicrobial resistance and outcome
Antibiotic resistance to recommended treatment was associated with an odds ratio of 1.22 (95% confidence interval 0.78 to 1.92) for fatal outcome. If only deaths after 24 hours of admission were examined, the association with a fatal outcome strengthened (odds ratio = 1.90, 0.95 to 3.80), but the possibility of no association could not be absolutely excluded.

Discussion

Syndromic rules effectively target children with invasive bacterial infections
Among acute paediatric admissions to a Kenyan district hospital, simple clinical syndromes based on WHO guidelines identified at admission 80% of children with an invasive bacterial infection and 93% of subsequent inpatient deaths. For every nine children with a defined syndrome indicating antibiotic treatment, one child had an identified invasive bacterial infection. Given the likely insensitivity of blood culture, we think this justifies empirical antibiotic treatment.

Does a positive malaria slide justify withholding antibiotics?
Overall, the presence of P falciparum parasitaemia was associated with a lower risk of invasive bacterial infection. However, where a syndrome requiring parenteral antibiotics was present, children with a positive malaria slide still had a risk of detectable invasive bacterial infection between 1 in 25 and 1 in 11 and a risk of dying between 1 in 28 and 1 in 6. We believe that these risks are too high to justify withholding parenteral antibiotics because a malaria slide is positive.

For children with the syndrome of mild pneumonia and a positive malaria slide, the case for withholding antibiotics strengthens: within this group, 1 in 33 had an identified invasive bacterial infection and 1 in 66 died. Given that blood cultures are less sensitive than other tests such as lung aspiration,6 7 that treatment with oral amoxicillin is relatively inexpensive, and that the overall potential antibiotic pressure on resistance exerted by this group would be small, dual treatment of children in hospital seems justified.

Recent reports suggest that the reading of malaria slides in the region is commonly unreliable, with frequent false positives.8 9 Among children with a clinical syndrome compatible with cerebral malaria, such false positives would have a 1 in 3 chance of invasive bacterial infection. Children with the mild pneumonia syndrome and a false positive malaria slide would have a 1 in 10 chance. The unreliability of malaria microscopy in practice further considerably strengthens the case for following syndromic indications for antibiotic treatment, irrespective of the malaria slide result.

Among those with an axillary temperature ≥39°C but without a defined syndromic indication for antibiotics, an accurate malaria slide may be helpful in deciding on antibiotic treatment: 1 in 10 of those with a negative malaria slide had an "occult" invasive bacterial infection, whereas invasive bacterial infection was rare in children with positive slides and the outcome significantly better, although we did not establish how many of these children actually received antibiotics.

Does a syndrome indicating antibiotic treatment justify withholding antimalarials?
A third of children with a syndrome requiring antibiotics had a P falciparum parasitaemia, and 24% of the deaths in this group were due to malaria in the absence of invasive bacterial infection. Thus, among children admitted to hospital, suspected or microscopically confirmed malaria should be treated with antimalarials regardless of any antibiotic treatment. Where the results of a malaria slide are unreliable, children with features of severe malaria (impaired consciousness, deep breathing, or both) should receive both parenteral antimalarials and antibiotics. Oral antimalarials are likely to be adequate for those not classified as severe.

Meningitis: problems with clinical diagnosis and antimicrobial resistance
One in four cases of meningitis presented without a clinical syndrome indicating parenteral antibiotic treatment. Results were similar when more detailed clinical indicators of meningitis were studied in this hospital.10 Meningitis was identified because our lumbar puncture protocol was broader than the syndrome definition. The pivotal role of lumbar puncture in rationalising treatment underlines the need to improve its use5: 88% of children with the syndrome did not have meningitis. Lumbar puncture therefore permits considerable cost savings, especially where there is significant resistance to inexpensive antibiotics.11 The high sensitivity to amoxicillin-gentamicin associated with this syndrome reflects the proportion of children with bacteraemia but not meningitis.


What is already known on this topic

Local data on bacterial aetiology and antimicrobial susceptibilities of childhood diseases are sparse in sub-Saharan Africa

Treatment guidelines for children in this setting tend to focus on individual diseases, which may lead to uncertainty where several possible causes of illness exist

The clinical manifestations of severe malaria overlap with those of invasive bacterial infection, and malaria microscopy may be unreliable, causing further uncertainty

What this study adds

A simple hierarchical classification of clinical syndromes seems to effectively target admissions with invasive bacterial infection and those at risk of death

A positive malaria slide does not seem to justify withholding parenteral antibiotic treatment where it is indicated by a syndrome requiring antibiotics

A practical approach is to make separate decisions regarding antibiotic, antimalarial, and other treatments on the basis of the presence of defined clinical syndromes and the results of any reliable laboratory investigations


Conclusions
Simple rules based on a hierarchical classification of WHO integrated management of childhood illness clinical syndromes can target admissions with invasive bacterial infections and those at risk of death. The antibiotic management of children admitted to hospital in settings with no or few diagnostic resources should reflect a comprehensive assessment of the sick child and not focus on single diseases (see checklist on bmj.com). Our data are limited by being from one district hospital and using in vitro susceptibility testing. Similar studies are needed from other areas, especially those with different prevalences of malaria and HIV.


{elps.f1}This is the abridged version of an article that was posted on bmj.com on 29 March 2005: http://bmj.com/cgi/doi/10.1136/bmj.38408.471991.8F

We thank the medical officer of health, hospital superintendent, and the clinicians, clinical assistants, and nursing staff of Kilifi District Hospital. We thank the director of the Centre for Geographic Medicine Research (coast), Norbert Peshu, for his support and guidance. We thank Tony Hart for his advice and support. This paper is published with the permission of the Director of the Kenya Medical Research Institute.

Contributors: See bmj.com

Funding: The study was supported by the Kenya Medical Research Institute and the Wellcome Trust. The funding sourceshad no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.

Competing interests: None declared.

Ethical approval: The Kenya Medical Research Institute national ethical and scientific review committees approved the study.

References

  1. World Health Organization. Management of the child with a serious infection or severe malnutrition: guidelines at the first referral level in developing countries. Geneva: WHO, 2000.
  2. English M, Berkley J, Mwangi I, Mohammed S, Ahmed M, Osier F, et al. Hypothetical performance of syndrome-based management of acute paediatric admissions of children aged more than 60 days in a Kenyan district hospital. Bull WHO 2003;81: 166-73.[Web of Science][Medline]
  3. Mbogo CM, Mwangangi JM, Nzovu J, Gu W, Yan G, Gunter JT, et al. Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg 2003;68: 734-42.[Abstract/Free Full Text]
  4. Ministry of Health, Republic of Kenya. AIDS in Kenya. 6th ed. Nairobi: Government of Kenya, 2001.
  5. Berkley JA, Mwangi I, Mwarumba S, Lowe B, Marsh K, Newton CRJC. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet 2001;357: 1753-7.[CrossRef][Web of Science][Medline]
  6. Falade AG, Mulholland EK, Adegbola RA, Greenwood BM. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop Paediatr 1997;17: 315-9.[Web of Science][Medline]
  7. Falade AG, Adegbola RA, Mulholland EK, Greenwood BM. Respiratory rate as a predictor of positive lung aspirates in young Gambian children with lobar pneumonia. Ann Trop Paediatr 2001;21: 293-7.[Medline]
  8. Makani J, Matuja W, Liyombo E, Snow RW, Marsh K, Warrell DA. Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description. Q J Med 2003;96: 355-62.[Web of Science][Medline]
  9. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004;329: 1212.[Abstract/Free Full Text]
  10. Berkley JA, Versteeg AC, Mwangi I, Lowe BS, Newton CR. Indicators of acute bacterial meningitis in children at a rural Kenyan district hospital. Pediatrics 2004;114: e713-9.[Abstract/Free Full Text]
  11. Duke T, Micheal A, Mokela D, Wal T, Reeder J. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries. Arch Dis Child 2003;88: 536-9.[Abstract/Free Full Text]
(Accepted 22 February 2005)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial
Hugh Reyburn, Hilda Mbakilwa, Rose Mwangi, Ombeni Mwerinde, Raimos Olomi, Chris Drakeley, and Christopher J M Whitty
BMJ 2007 334: 403. [Abstract] [Full Text] [PDF]

Clinical syndromes seem adequate for targeting drug prescribing
BMJ 2005 330: 0. [Full Text]

Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study
Hugh Reyburn, Redepmta Mbatia, Chris Drakeley, Ilona Carneiro, Emmanuel Mwakasungula, Ombeni Mwerinde, Kapalala Saganda, John Shao, Andrew Kitua, Raimos Olomi, Brian M Greenwood, and Christopher J M Whitty
BMJ 2004 329: 1212. [Abstract] [Full Text] [PDF]

Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study
J A Berkley, A Ross, I Mwangi, F H A Osier, M Mohammed, M Shebbe, B S Lowe, K Marsh, and C R J C Newton
BMJ 2003 326: 361. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Sayang, C., Soula, G., Tahar, R., Basco, L. K., Gazin, P., Moyou-Somo, R., Delmont, J. (2009). Use of a Histidine-Rich Protein 2-Based Rapid Diagnostic Test for Malaria by Health Personnel during Routine Consultation of Febrile Outpatients in a Peripheral Health Facility in Yaounde, Cameroon. Am J Trop Med Hyg 81: 343-347 [Abstract] [Full text]  
  • Murray, C. K., Gasser, R. A. Jr., Magill, A. J., Miller, R. S. (2008). Update on Rapid Diagnostic Testing for Malaria. Clin. Microbiol. Rev. 21: 97-110 [Abstract] [Full text]  
  • Gwer, S., Newton, C. R.J.C., Berkley, J. A. (2007). Over-Diagnosis and Co-Morbidity of Severe Malaria in African Children: A Guide for Clinicians. Am J Trop Med Hyg 77: 6-13 [Abstract] [Full text]  
  • Lamikanra, A. A., Brown, D., Potocnik, A., Casals-Pascual, C., Langhorne, J., Roberts, D. J. (2007). Malarial anemia: of mice and men. Blood 110: 18-28 [Abstract] [Full text]  
  • Seaton, C., Ignas, J., Muchohi, S., Kokwaro, G., Maitland, K., Thomson, A. H. (2007). Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition. J Antimicrob Chemother 59: 681-689 [Abstract] [Full text]  
  • Reyburn, H., Mbakilwa, H., Mwangi, R., Mwerinde, O., Olomi, R., Drakeley, C., Whitty, C. J M (2007). Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ 334: 403-403 [Abstract] [Full text]  
  • POLAGE, C. R., BEDU-ADDO, G., OWUSU-OFORI, A., FRIMPONG, E., LLOYD, W., ZURCHER, E., HALE, D., PETTI, C. A. (2006). LABORATORY USE IN GHANA: PHYSICIAN PERCEPTION AND PRACTICE.. Am J Trop Med Hyg 75: 526-531 [Abstract] [Full text]  
  • Scott, J. A. G., Mwarumba, S., Ngetsa, C., Njenga, S., Lowe, B. S., Slack, M. P. E., Berkley, J. A., Mwangi, I., Maitland, K., English, M., Marsh, K. (2005). Progressive Increase in Antimicrobial Resistance among Invasive Isolates of Haemophilus influenzae Obtained from Children Admitted to a Hospital in Kilifi, Kenya, from 1994 to 2002. Antimicrob. Agents Chemother. 49: 3021-3024 [Abstract] [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ